Clinical Trials
19 trialsNCT07601243 2026-05-22
Study of GS-2426 in Participants With Advanced Solid Tumors
Gilead Sciences
Phase 1 Not yet recruiting
NCT07601334 2026-05-22
Safety and Activity of HF50 in Patients With Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase 1 Not yet recruiting
NCT07596381 2026-05-19
FAK Inhibitor in Patients With Advanced Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1 Not yet recruiting
NCT07593144 2026-05-18
A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
Foresight Therapeutics (Hefei) Co., Ltd.
Phase 1 Not yet recruiting
NCT07591285 2026-05-15
A Study of SYS6051 in Subjects With Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1 Not yet recruiting
NCT07482319 2026-03-23
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
Beijing Geekgene Technology Co., LTD
Phase 1 Not yet recruiting
NCT07275853 2025-12-10
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
TCRx Therapeutics Co.Ltd
Phase 1 Not yet recruiting
NCT07207681 2025-10-06
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
The First Hospital of Jilin University
Phase 1 Not yet recruiting
NCT07136558 2025-08-22
Evaluation of ICP-B794 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1 Not yet recruiting
NCT07101549 2025-08-03
Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase 1 Not yet recruiting
NCT06998173 2025-05-31
Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor
Danatlas Pharmaceuticals Co., Ltd
Phase 1 Not yet recruiting
NCT06963398 2025-05-09
A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06932094 2025-04-23
Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT06925659 2025-04-17
A Study of QLM2011 in Subjects With Advanced Solid Tumors
Qilu Pharmaceutical (Hainan) Co., Ltd.
Phase 1 Not yet recruiting
NCT06885645 2025-04-03
First-In-Human Study in Participants With Advanced Solid Tumors
Chengdu Kanghong Biotech Co., Ltd.
Phase 1 Not yet recruiting
NCT06598735 2024-09-19
A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Not yet recruiting
NCT06364501 2024-08-07
Phase 1 Trial of KH801
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT06134531 2023-11-18
First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors
Nanfang Hospital, Southern Medical University
Phase 1 Not yet recruiting
NCT05804864 2023-04-07
A Study of KM501 in Patients With Solid Tumors
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 1 Not yet recruiting